Literature DB >> 20354929

Primary graft dysfunction: definition, risk factors, short- and long-term outcomes.

James C Lee1, Jason D Christie, Shaf Keshavjee.   

Abstract

Primary graft dysfunction (PGD) is a form of early lung graft dysfunction that is a major cause of early morbidity and mortality following lung transplantation. Survivors of PGD have decreased long-term lung function and an increased risk of developing bronchiolitis obliterans syndrome (BOS), a manifestation of chronic graft dysfunction. This article reviews the current definition, contributing factors, and guidelines for grading clinical PGD, as well as controversies surrounding them. The current literature examining clinical risk factors for PGD is summarized, as are studies exploring molecular and biochemical markers for PGD prediction and severity. Studies examining the short- and long-term effects of PGD on lung transplant outcomes are reviewed. Lastly, we highlight the emerging concepts in lung transplantation that will potentially impact PGD incidence and outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20354929     DOI: 10.1055/s-0030-1249111

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  40 in total

1.  CASE 7--2014 Rescue therapy with early extracorporeal membrane oxygenation for primary graft dysfunction after bilateral lung transplantation.

Authors:  Ali M Farooki; Heidi Bazick-Cuschieri; Emily K Gordon; James C Lee; Edward C Cantu; John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-08-30       Impact factor: 2.628

2.  Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.

Authors:  Julie A Bastarache; Joshua M Diamond; Steven M Kawut; David J Lederer; Lorraine B Ware; Jason D Christie
Journal:  Gend Med       Date:  2012-02-22

3.  Risk factors and outcome of primary graft dysfunction after lung transplantation in Korea.

Authors:  Sungwoo Moon; Moo Suk Park; Jin Gu Lee; Ji Ye Jung; Young Ae Kang; Young Sam Kim; Se Kyu Kim; Joon Chang; Hyo Chae Paik; Song Yee Kim
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 4.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

5.  Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.

Authors:  David M Sayah; Beñat Mallavia; Fengchun Liu; Guadalupe Ortiz-Muñoz; Axelle Caudrillier; Ariss DerHovanessian; David J Ross; Joseph P Lynch; Rajan Saggar; Abbas Ardehali; Lorraine B Ware; Jason D Christie; John A Belperio; Mark R Looney
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

Review 6.  Lung volume reduction followed by lung transplantation-considerations on selection criteria and outcome.

Authors:  Alexis Slama; Christian Taube; Markus Kamler; Clemens Aigner
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

7.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

8.  Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation.

Authors:  E Cantu; D J Lederer; K Meyer; K Milewski; Y Suzuki; R J Shah; J M Diamond; N J Meyer; J W Tobias; D A Baldwin; V M Van Deerlin; K M Olthoff; A Shaked; J D Christie
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

9.  Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant.

Authors:  Mary K Porteous; Bonnie Ky; James N Kirkpatrick; Russell Shinohara; Joshua M Diamond; Rupal J Shah; James C Lee; Jason D Christie; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

10.  Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome.

Authors:  R J Shah; S L Bellamy; J C Lee; E Cantu; J M Diamond; N Mangalmurti; S M Kawut; L B Ware; J D Christie
Journal:  Am J Transplant       Date:  2013-01-17       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.